Generics Global Industry Guide 2013-2022

MarketLine
263 Pages - MLINE12771
$1,495.00

Summary

Global Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Questions Answered:

- What was the size of the global generics market by value in 2017?
- What will be the size of the global generics market in 2022?
- What factors are affecting the strength of competition in the global generics market?
- How has the market performed over the last five years?
- How large is the global generics market in relation to its regional counterparts?

Scope

Essential resource for top-line data and analysis covering the global generics market. Includes market size data, textual and graphical analysis of market growth trends and leading companies.

- For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included.
- The market value is evaluated at ex-factory prices.
- Market volume is quantified here as the percentage of the total ethical pharmaceutical market volume in a country or region which is accounted for by generic drugs. It is therefore a generics penetration rate measure, not an absolute measure of market volume.
- Regional volumes are calculated as weighted averages of countries which make up the region in question where volume data exists.
- Note that any volumes of "1" (one) or 100% are due to rounding as MarketLine does not believe that generics will ever fully represent 100% of the medicinal market in any country or region.
- All currency conversions were calculated at constant average annual 2017 exchange rates.
- The global generics market had total revenues of $307.6bn in 2017, representing a compound annual growth rate (CAGR) of 8.2% between 2013 and 2017.
- Market consumption volume increased with a CAGR of 1.9% between 2013 and 2017, to reach a total of 70.2% in 2017.
- The US is the largest market in the world; it made up 33.5% of the global value in 2017. Other large markets include China, Japan, Germany, and India.

Reasons to buy

- Save time carrying out entry-level research by identifying the size, growth, and leading players in the global generics market
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the global generics market
- Leading company profiles reveal details of key generics market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the global generics market with five year forecasts by both value and volume

'

Table of Contents
EXECUTIVE SUMMARY 2
Market value 2
Market value forecast 2
Market volume 2
Market volume forecast 2
Geography segmentation 2
Introduction 20
What is this report about? 20
Who is the target reader? 20
How to use this report 20
Definitions 20
Global Generics 21
Market Overview 21
Market Data 23
Market Segmentation 25
Market outlook 26
Five forces analysis 28
Generics in Asia-Pacific 34
Market Overview 34
Market Data 36
Market Segmentation 38
Market outlook 39
Five forces analysis 41
Generics in Europe 47
Market Overview 47
Market Data 49
Market Segmentation 51
Market outlook 52
Five forces analysis 54
Generics in France 60
Market Overview 60
Market Data 61
Market Segmentation 63
Market outlook 64
Five forces analysis 66
Macroeconomic indicators 72
Generics in Germany 74
Market Overview 74
Market Data 75
Market Segmentation 77
Market outlook 78
Five forces analysis 80
Macroeconomic indicators 86
Generics in Italy 88
Market Overview 88
Market Data 89
Market Segmentation 91
Market outlook 92
Five forces analysis 94
Macroeconomic indicators 100
Generics in Japan 102
Market Overview 102
Market Data 103
Market Segmentation 105
Market outlook 106
Five forces analysis 108
Macroeconomic indicators 114
Generics in Australia 116
Market Overview 116
Market Data 117
Market Segmentation 119
Market outlook 120
Five forces analysis 122
Macroeconomic indicators 128
Generics in Canada 130
Market Overview 130
Market Data 131
Market Segmentation 133
Market outlook 134
Five forces analysis 136
Macroeconomic indicators 143
Generics in China 145
Market Overview 145
Market Data 146
Market Segmentation 148
Market outlook 149
Five forces analysis 151
Macroeconomic indicators 158
Generics in The Netherlands 160
Market Overview 160
Market Data 161
Market Segmentation 163
Market outlook 164
Five forces analysis 166
Macroeconomic indicators 172
Generics in Spain 174
Market Overview 174
Market Data 175
Market Segmentation 177
Market outlook 178
Five forces analysis 180
Macroeconomic indicators 186
Generics in The United Kingdom 188
Market Overview 188
Market Data 189
Market Segmentation 191
Market outlook 192
Five forces analysis 194
Macroeconomic indicators 201
Generics in The United States 203
Market Overview 203
Market Data 204
Market Segmentation 206
Market outlook 207
Five forces analysis 209
Macroeconomic indicators 215
Company Profiles 217
Leading Companies 217
Appendix 261
Methodology 261
About MarketLine 262

List of Tables
Table 1: Global generics market value: $ billion, 2013-17
Table 2: Global generics market volume: % of total pharma, 2013-17
Table 3: Global generics market geography segmentation: $ billion, 2017
Table 4: Global generics market value forecast: $ billion, 2017-22
Table 5: Global generics market volume forecast: % of total pharma, 2017-22
Table 6: Asia-Pacific generics market value: $ billion, 2013-17
Table 7: Asia-Pacific generics market volume: % of total pharma, 2013-17
Table 8: Asia-Pacific generics market geography segmentation: $ billion, 2017
Table 9: Asia-Pacific generics market value forecast: $ billion, 2017-22
Table 10: Asia-Pacific generics market volume forecast: % of total pharma, 2017-22
Table 11: Europe generics market value: $ billion, 2013-17
Table 12: Europe generics market volume: % of total pharma, 2013-17
Table 13: Europe generics market geography segmentation: $ billion, 2017
Table 14: Europe generics market value forecast: $ billion, 2017-22
Table 15: Europe generics market volume forecast: % of total pharma, 2017-22
Table 16: France generics market value: $ million, 2013-17
Table 17: France generics market volume: % of total pharma, 2013-17
Table 18: France generics market geography segmentation: $ million, 2017
Table 19: France generics market value forecast: $ million, 2017-22
Table 20: France generics market volume forecast: % of total pharma, 2017-22
Table 21: France size of population (million), 2013-17
Table 22: France gdp (constant 2005 prices, $ billion), 2013-17
Table 23: France gdp (current prices, $ billion), 2013-17
Table 24: France inflation, 2013-17
Table 25: France consumer price index (absolute), 2013-17
Table 26: France exchange rate, 2013-17
Table 27: Germany generics market value: $ million, 2013-17
Table 28: Germany generics market volume: % of total pharma, 2013-17
Table 29: Germany generics market geography segmentation: $ million, 2017
Table 30: Germany generics market value forecast: $ million, 2017-22
Table 31: Germany generics market volume forecast: % of total pharma, 2017-22
Table 32: Germany size of population (million), 2013-17
Table 33: Germany gdp (constant 2005 prices, $ billion), 2013-17
Table 34: Germany gdp (current prices, $ billion), 2013-17
Table 35: Germany inflation, 2013-17
Table 36: Germany consumer price index (absolute), 2013-17
Table 37: Germany exchange rate, 2013-17
Table 38: Italy generics market value: $ million, 2013-17
Table 39: Italy generics market volume: % of total pharma, 2013-17
Table 40: Italy generics market geography segmentation: $ million, 2017
Table 41: Italy generics market value forecast: $ million, 2017-22
Table 42: Italy generics market volume forecast: % of total pharma, 2017-22
Table 43: Italy size of population (million), 2013-17
Table 44: Italy gdp (constant 2005 prices, $ billion), 2013-17
Table 45: Italy gdp (current prices, $ billion), 2013-17
Table 46: Italy inflation, 2013-17
Table 47: Italy consumer price index (absolute), 2013-17
Table 48: Italy exchange rate, 2013-17
Table 49: Japan generics market value: $ million, 2013-17
Table 50: Japan generics market volume: % of total pharma, 2013-17

List of Figures
Figure 1: Global generics market value: $ billion, 2013-17
Figure 2: Global generics market volume: % of total pharma, 2013-17
Figure 3: Global generics market geography segmentation: % share, by value, 2017
Figure 4: Global generics market value forecast: $ billion, 2017-22
Figure 5: Global generics market volume forecast: % of total pharma, 2017-22
Figure 6: Forces driving competition in the global generics market, 2017
Figure 7: Drivers of buyer power in the global generics market, 2017
Figure 8: Drivers of supplier power in the global generics market, 2017
Figure 9: Factors influencing the likelihood of new entrants in the global generics market, 2017
Figure 10: Factors influencing the threat of substitutes in the global generics market, 2017
Figure 11: Drivers of degree of rivalry in the global generics market, 2017
Figure 12: Asia-Pacific generics market value: $ billion, 2013-17
Figure 13: Asia-Pacific generics market volume: % of total pharma, 2013-17
Figure 14: Asia-Pacific generics market geography segmentation: % share, by value, 2017
Figure 15: Asia-Pacific generics market value forecast: $ billion, 2017-22
Figure 16: Asia-Pacific generics market volume forecast: % of total pharma, 2017-22
Figure 17: Forces driving competition in the generics market in Asia-Pacific, 2017
Figure 18: Drivers of buyer power in the generics market in Asia-Pacific, 2017
Figure 19: Drivers of supplier power in the generics market in Asia-Pacific, 2017
Figure 20: Factors influencing the likelihood of new entrants in the generics market in Asia-Pacific, 2017
Figure 21: Factors influencing the threat of substitutes in the generics market in Asia-Pacific, 2017
Figure 22: Drivers of degree of rivalry in the generics market in Asia-Pacific, 2017
Figure 23: Europe generics market value: $ billion, 2013-17
Figure 24: Europe generics market volume: % of total pharma, 2013-17
Figure 25: Europe generics market geography segmentation: % share, by value, 2017
Figure 26: Europe generics market value forecast: $ billion, 2017-22
Figure 27: Europe generics market volume forecast: % of total pharma, 2017-22
Figure 28: Forces driving competition in the generics market in Europe, 2017
Figure 29: Drivers of buyer power in the generics market in Europe, 2017
Figure 30: Drivers of supplier power in the generics market in Europe, 2017
Figure 31: Factors influencing the likelihood of new entrants in the generics market in Europe, 2017
Figure 32: Factors influencing the threat of substitutes in the generics market in Europe, 2017
Figure 33: Drivers of degree of rivalry in the generics market in Europe, 2017
Figure 34: France generics market value: $ million, 2013-17
Figure 35: France generics market volume: % of total pharma, 2013-17
Figure 36: France generics market geography segmentation: % share, by value, 2017
Figure 37: France generics market value forecast: $ million, 2017-22
Figure 38: France generics market volume forecast: % of total pharma, 2017-22
Figure 39: Forces driving competition in the generics market in France, 2017
Figure 40: Drivers of buyer power in the generics market in France, 2017
Figure 41: Drivers of supplier power in the generics market in France, 2017
Figure 42: Factors influencing the likelihood of new entrants in the generics market in France, 2017
Figure 43: Factors influencing the threat of substitutes in the generics market in France, 2017
Figure 44: Drivers of degree of rivalry in the generics market in France, 2017
Figure 45: Germany generics market value: $ million, 2013-17
Figure 46: Germany generics market volume: % of total pharma, 2013-17
Figure 47: Germany generics market geography segmentation: % share, by value, 2017
Figure 48: Germany generics market value forecast: $ million, 2017-22
Figure 49: Germany generics market volume forecast: % of total pharma, 2017-22
Figure 50: Forces driving competition in the generics market in Germany, 2017
Figure 51: Drivers of buyer power in the generics market in Germany, 2017
Figure 52: Drivers of supplier power in the generics market in Germany, 2017
Figure 53: Factors influencing the likelihood of new entrants in the generics market in Germany, 2017
Figure 54: Factors influencing the threat of substitutes in the generics market in Germany, 2017

$1,495.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838



Browse All Reports